681674 Sigma-AldrichWnt Pathway Inhibitor XI, CCT036477 - CAS 305372-78-5 - Calbiochem
The Wnt Pathway Inhibitor XI, CCT036477, also referenced under CAS 305372-78-5, controls the biological activity of Wnt Pathway. This small molecule/inhibitor is primarily used for Cancer applications.
More>> The Wnt Pathway Inhibitor XI, CCT036477, also referenced under CAS 305372-78-5, controls the biological activity of Wnt Pathway. This small molecule/inhibitor is primarily used for Cancer applications. Less<<Sinónimos: CCT036477, CRT Inhibitor VI, β-Catenin/Tcf Inhibitor VI
Productos recomendados
Descripción
Replacement Information |
---|
Tabla espec. clave
CAS # | Empirical Formula |
---|---|
305372-78-5 | C₂₁H₁₈ClN₃ |
Products
Número de referencia | Embalaje | Cant./Env. | |
---|---|---|---|
681674-5MG | Frasco de vidrio | 5 mg |
References | |
---|---|
References | Ewan, K., et al. 2010. Cancer Res. 70, 5963. |
Product Information | |
---|---|
CAS number | 305372-78-5 |
Form | Off-white solid |
Hill Formula | C₂₁H₁₈ClN₃ |
Chemical formula | C₂₁H₁₈ClN₃ |
Structure formula Image | |
Quality Level | MQ100 |
Applications |
---|
Biological Information | |
---|---|
Purity | ≥95% by 1H NMR |
Physicochemical Information |
---|
Dimensions |
---|
Materials Information |
---|
Toxicological Information |
---|
Safety Information according to GHS |
---|
Safety Information |
---|
Product Usage Statements |
---|
Packaging Information | |
---|---|
Packaged under inert gas | Packaged under inert gas |
Transport Information |
---|
Supplemental Information |
---|
Specifications |
---|
Global Trade Item Number | |
---|---|
Número de referencia | GTIN |
681674-5MG | 04055977225228 |
Documentation
Wnt Pathway Inhibitor XI, CCT036477 - CAS 305372-78-5 - Calbiochem Ficha datos de seguridad (MSDS)
Título |
---|
Wnt Pathway Inhibitor XI, CCT036477 - CAS 305372-78-5 - Calbiochem Certificados de análisis
Cargo | Número de lote |
---|---|
681674 |
Referencias bibliográficas
Visión general referencias |
---|
Ewan, K., et al. 2010. Cancer Res. 70, 5963. |